Strategic Expansion BioDot recently expanded its footprint with a new Irvine, California headquarters, signaling potential for regional sales initiatives, local technical support expansions, and closer collaboration with North American life sciences customers.

PartnershipDriven Growth Recent and notable collaborations, such as the Empire Genomics partnership to launch hematology-focused FISH probe panels, create cross-sell opportunities for BioDot’s CellWriter and FISH-related dispensing solutions.

High-Volume Diagnostics With over 3 billion diagnostics tests annually supported by BioDot’s liquid dispensing technologies, there is strong demand potential in contract manufacturing, CROs, and diagnostic manufacturers seeking scalable, low-volume to high-throughput dispensing solutions.

Cytogenetics & FISH Focus BioDot’s work in cytogenetics and FISH-based assays presents a sales angle to labs and manufacturers needing automated, high-precision dispensing for fluorescence in situ hybridization workflows and related genetic analysis.

Integrated Solutions BioDot’s broad portfolio (BioJet, Lyobead, low-volume PCR, lateral flow, microfluidics, and array technologies) enables cross-sell of modular dispensing platforms to life sciences companies pursuing end-to-end automation and assay development across diagnostics, drug development, and biosensing.